Recent advances in immunology and biology have opened new horizons in cancer therapy-including immunotherapies and cancer vaccines-for both solid and blood borne cancers. This book is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. It discusses "theranostics" as pertaining to immunotherapy, presents the new paradigm of biomarker guided R&D, and discusses clinical development. The book also reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.